ASH 2021 | Advancing CAR-T in multiple myeloma
Andrew Cowan
• 11 Dec 2021
Andrew Cowan, MD, University of Washington, Seattle, WA, discusses how the use of CAR T-cell therapy is likely to advance in the coming years, commenting on the need for better management of toxicities and improved patient access. This interview took place at during 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.
